No Data
No Data
Does Tinavi Medical TechnologiesLtd (SHSE:688277) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' So it might be obvious
Tianzhihang (688277.SH) reported first-quarter results with a net loss of 1.00632 million yuan
Tianzhihang (688277.SH) released its report for the first quarter of 2024. The company achieved operating income of 2 during the reporting period...
Tianzhihang (688277.SH) announced 2023 annual results with a net loss of 156 million yuan
Tianzhihang (688277.SH) disclosed its 2023 annual report, and the company achieved revenue of 2.1 in 2023...
Tinavi Medical Technologies Co.,Ltd. (SHSE:688277) May Have Run Too Fast Too Soon With Recent 26% Price Plummet
Unfortunately for some shareholders, the Tinavi Medical Technologies Co.,Ltd. (SHSE:688277) share price has dived 26% in the last thirty days, prolonging recent pain. For any long-term shareholders
Tianzhihang (688277.SH) plans to join the joint venture Beijing Ruihuachen Medical Technology Co., Ltd.
Tianzhihang (688277.SH) issued an announcement that the company plans to jointly fund the establishment with 3 other investors in the form of currency...
Tianzhihang (688277.SH): net loss of 161 million yuan in 2023
Gelonghui, Feb. 26: Tianzhihang (688277.SH) announced its 2023 annual performance report. During the reporting period, the company achieved operating income of 209.374 million yuan, an increase of 34.41% over the same period of the previous year; net profit loss attributable to owners of the parent company was RMB 169.93212 million, an increase of 45.53% over the same period last year; net profit loss attributable to owners of the parent company after deducting non-recurring profit and loss was 209.787 million yuan, an increase of 57.20% over the same period last year.
No Data